Iron biomarker or covariate | Multivariable-adjusted β (95% CI) | p-value |
---|---|---|
CSF iron | ||
 Age | −0.014 (−0.055, 0.027) | n.s. |
 Sex (women vs. men) | 0.258 (−0.347, 0.864) | n.s. |
 Race/ethnicitya | 0.732 (0.108, 1.36) | 0.02 |
 Detectable plasma virus (Y vs. N) | 0.611 (−0.022, 1.24) | 0.06b |
 Log10 (CSF HIV RNA concentration) | −0.581 (−1.09, −0.072) | 0.03 |
 ART on vs. off | 0.234 (−0.544, 1.01) | n.s. |
 QAlb | 0.215 (0.023, 0.407) | 0.03 |
 Comorbidity (mild-moderate vs. minimal) | 0.098 (−0.466, 0.661) | n.s. |
CSF transferrin | ||
 Age | 0.005 (−0.016, 0.025) | n.s. |
 Sex (women vs. men) | −0.389 (−0.750, −0.029) | 0.03 |
 Race/ethnicity | −0.100 (−0.202, 0.002) | 0.06 b |
 Detectable plasma virus (Y vs. N) | −0.322 (−0.736, 0.090) | n.s. |
 Log10 (CSF HIV RNA concentration) | 0.380 (0.001, 0.760) | 0.05 c |
 ART on vs. off | 0.801 (0.067, 1.54) | 0.03 |
 Current ZDV use (Y vs. N) | 0.009 (−0.364, 0.381) | n.s. |
 QAlb | 0.723 (0.346, 1.10) | <0.01 |
 Comorbidity (mild-moderate vs. minimal) | 0.007 (−0.299, 0.313) | n.s. |
CSF H-ferritin | ||
 Age | 0.734 (−0.438, 1.91) | n.s. |
 Sex (women vs. men) | 0.022 (−0.482, 0.487) | n.s. |
 Race/ethnicity | −0.036 (−0.378, 0.305) | n.s. |
 Detectable plasma virus (Y vs. N) | −0.407 (−0.780, −0.033) | 0.03 |
 Log10 (CSF HIV RNA concentration) | 0.277 (−0.129, 0.683) | n.s. |
 ART on vs. off | 0.688 (−0.197,1.57) | n.s. |
 QAlb | 0.084 (−0.006, 0.173) | n.s. |
 Comorbidity (mild-moderate vs. minimal) | 0.416 (0.038, 0.793) | 0.03 |